Symbols / ICCT Stock $0.00 +300.00% iCoreConnect Inc.

Healthcare • Health Information Services • United States • PNK
ICCT (Stock) Chart
About

iCoreConnect Inc. develops and markets health insurance portability and accountability act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company offers iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, an add-on for iCoreRx that integrates with state databases to automate prescription drug monitoring; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patient insurance eligibility breakdown to verify their benefits; iCoreClaims for processing and managing claims submitted by policyholders or dental care provider; and iCoreHuddle and iCoreHuddle+, which reveals the revenue potential of each patient. It also provides iCoreCodeGenius, a medical coding reference SaaS solution; iCoreExchange, a HIPAA compliant SaaS email solution using direct protocol that allows doctors to send and receive secure email with attachments to and from other healthcare professionals in the network; iCoreCloud provides the ability to backup on-premise servers and computers to the cloud; iCorePay, a cloud-based financial technology solution designed to streamline the billing and payment processes for healthcare providers; iCoreSecure, a secure SaaS solution that solves privacy concerns; and iCoreIT. In addition, the company offers iCoreVerify provides automated insurance verifications; iCoreVerify+ that combines automation with concierge assistance for verification; and iCoreVerifyPro, it manages all verifications, entering insurance benefits directly into patient charts, ensuring insurance information. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. The company was founded in 1992 and is headquartered in Ocoee, Florida. On June 2, 2025, iCoreConnect Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Health Information Servi Market Cap 9.75K
Enterprise Value 1.98M Income -33.20M Sales 10.75M
Book/sh -4.74 Cash/sh 0.00 Dividend Yield —
Payout 0.00% Employees 17 IPO —
P/E — Forward P/E — PEG —
P/S 0.00 P/B -0.00 P/C —
EV/EBITDA -0.16 EV/Sales 0.18 Quick Ratio 0.08
Current Ratio 0.10 Debt/Eq — LT Debt/Eq —
EPS (ttm) -45.78 EPS next Y 0.00 EPS Growth —
Revenue Growth — Earnings — ROA -90.67%
ROE — ROIC — Gross Margin 76.77%
Oper. Margin -7.72% Profit Margin -289.93% Shs Outstand 4.88M
Shs Float 31.34M Short Float 18.16% Short Ratio 0.01
Short Interest — 52W High 8.20 52W Low 0.00
Beta 33.47 Avg Volume 1.97K Volume 8.70K
Target Price — Recom None Prev Close $0.00
Price $0.00 Change 300.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$8.58
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
News
RSS: Latest ICCT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-04-28 SCHONFELD STRATEGIC ADVISORS LLC Beneficial Owner of more than 10% of a Class of Security — 132,378 $2.24 $299,500
2025-04-21 MCDERMOTT KEVIN PATRICK Director — 6,697 $2.24 $15,001
2025-04-21 KALISH WAYNE EDWARD Director — 8,929 $2.24 $20,001
2025-04-21 MCDERMOTT ROBERT P Chief Executive Officer — 8,929 $2.24 $20,001
2025-04-21 SHAH ARCHIT Chief Financial Officer — 4,465 $2.24 $10,002
2025-04-21 PASQUAL JOHN Director — 8,929 $2.24 $20,001
2025-04-21 HYLAND YVONNE E Director — 6,433 $2.24 $14,410
2025-04-21 SCHONFELD STRATEGIC ADVISORS LLC Beneficial Owner of more than 10% of a Class of Security — 146,800 $2.02 $372,143
2025-04-21 SCHONFELD STRATEGIC ADVISORS LLC Beneficial Owner of more than 10% of a Class of Security — 41,400 $1.91 $79,589
2024-12-31 MCDERMOTT KEVIN PATRICK Director — 6,000 $2.50 $15,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
10.75
+31.83%
8.15
+2.05%
7.99
+61.16%
4.96
Operating Revenue
10.75
+31.83%
8.15
+2.05%
7.99
+61.16%
4.96
Cost Of Revenue
2.50
+23.03%
2.03
-9.54%
2.24
+41.94%
1.58
Reconciled Cost Of Revenue
2.50
+23.03%
2.03
-9.54%
2.24
+41.98%
1.58
Gross Profit
8.25
+34.75%
6.12
+6.58%
5.74
+70.15%
3.38
Operating Expense
23.76
+44.87%
16.40
+55.49%
10.55
+58.27%
6.66
Selling General And Administration
20.75
+37.23%
15.12
+63.42%
9.25
+76.86%
5.23
Total Expenses
26.25
+42.46%
18.43
+44.08%
12.79
+55.14%
8.24
Operating Income
-15.51
-50.89%
-10.28
-114.00%
-4.80
-46.07%
-3.29
Total Operating Income As Reported
-15.51
-50.89%
-10.28
-114.00%
-4.80
-46.07%
-3.29
EBITDA
-26.73
-102.97%
-13.17
-228.99%
-4.00
-32.00%
-3.03
Normalized EBITDA
-14.78
-37.48%
-10.75
-168.58%
-4.00
-19.04%
-3.36
Reconciled Depreciation
3.00
+135.50%
1.27
-1.33%
1.29
-9.72%
1.43
EBIT
-29.73
-105.84%
-14.44
-172.78%
-5.29
-18.62%
-4.46
Total Unusual Items
-11.95
-394.12%
-2.42
0.00
-100.00%
0.33
Total Unusual Items Excluding Goodwill
-11.95
-394.12%
-2.42
0.00
-100.00%
0.33
Special Income Charges
-5.65
-5248.11%
-0.11
0.00
-100.00%
0.33
Other Special Charges
—
—
—
-0.33
Impairment Of Capital Assets
6.63
+6175.66%
0.11
0.00
—
Net Income
-31.16
-100.34%
-15.55
-155.79%
-6.08
-22.47%
-4.96
Pretax Income
-31.16
-100.34%
-15.55
-155.79%
-6.08
-22.47%
-4.96
Net Non Operating Interest Income Expense
-3.26
-36.13%
-2.40
-97.83%
-1.21
+39.84%
-2.01
Interest Expense Non Operating
1.43
+28.76%
1.11
+41.25%
0.79
+56.81%
0.50
Net Interest Income
-3.26
-36.13%
-2.40
-97.83%
-1.21
+39.84%
-2.01
Interest Expense
1.43
+28.76%
1.11
+41.25%
0.79
+56.81%
0.50
Other Income Expense
-12.39
-330.42%
-2.88
-4267.32%
-0.07
-119.52%
0.34
Other Non Operating Income Expenses
-0.44
+4.42%
-0.46
-598.05%
-0.07
-978.92%
0.01
Gain On Sale Of Security
-6.30
-172.27%
-2.31
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-31.16
-100.34%
-15.55
-155.79%
-6.08
-22.47%
-4.96
Net Income From Continuing Operation Net Minority Interest
-31.16
-100.34%
-15.55
-155.79%
-6.08
-22.47%
-4.96
Net Income From Continuing And Discontinued Operation
-31.16
-100.34%
-15.55
-155.79%
-6.08
-22.47%
-4.96
Net Income Continuous Operations
-31.16
-100.34%
-15.55
-155.79%
-6.08
-22.47%
-4.96
Normalized Income
-19.21
-46.26%
-13.13
-116.02%
-6.08
-14.84%
-5.29
Net Income Common Stockholders
-33.20
-108.55%
-15.92
-102.18%
-7.87
-58.63%
-4.96
Otherunder Preferred Stock Dividend
0.00
0.00
-100.00%
1.79
—
Diluted EPS
—
-43.32
-67.14%
-25.92
-46.53%
-17.69
Basic EPS
—
-43.32
-67.14%
-25.92
-46.53%
-17.69
Basic Average Shares
—
0.37
+20.95%
0.30
+8.26%
0.28
Diluted Average Shares
—
0.37
+20.95%
0.30
+8.26%
0.28
Diluted NI Availto Com Stockholders
-33.20
-108.55%
-15.92
-102.18%
-7.87
-58.63%
-4.96
Depreciation Amortization Depletion Income Statement
3.00
+135.50%
1.27
-1.33%
1.29
-9.70%
1.43
Depreciation And Amortization In Income Statement
3.00
+135.50%
1.27
-1.33%
1.29
-9.70%
1.43
Gain On Sale Of PPE
0.98
0.00
—
—
Preferred Stock Dividends
2.04
+454.62%
0.37
-79.46%
1.79
—
Total Other Finance Cost
1.84
+42.48%
1.29
+202.03%
0.43
-71.82%
1.51
Line Item Trend 2023-12-31
Total Assets
15.69
Current Assets
3.51
Cash Cash Equivalents And Short Term Investments
1.22
Cash And Cash Equivalents
1.22
Cash Financial
1.22
Receivables
0.56
Accounts Receivable
0.56
Gross Accounts Receivable
0.67
Allowance For Doubtful Accounts Receivable
-0.10
Prepaid Assets
—
Other Current Assets
1.73
Total Non Current Assets
12.18
Net PPE
1.32
Gross PPE
1.40
Accumulated Depreciation
-0.08
Properties
0.00
Machinery Furniture Equipment
0.22
Other Properties
1.14
Leases
0.04
Goodwill And Other Intangible Assets
5.37
Goodwill
1.48
Other Intangible Assets
3.88
Other Non Current Assets
—
Total Liabilities Net Minority Interest
11.24
Current Liabilities
8.88
Payables And Accrued Expenses
3.24
Current Debt And Capital Lease Obligation
5.51
Current Debt
5.27
Other Current Borrowings
5.27
Current Capital Lease Obligation
0.24
Current Deferred Liabilities
0.12
Current Deferred Revenue
0.12
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
2.37
Long Term Debt And Capital Lease Obligation
2.37
Long Term Debt
1.42
Long Term Capital Lease Obligation
0.95
Non Current Deferred Liabilities
—
Non Current Deferred Revenue
—
Stockholders Equity
4.44
Common Stock Equity
4.44
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
0.50
Ordinary Shares Number
0.50
Treasury Shares Number
0.00
Additional Paid In Capital
119.48
Retained Earnings
-115.04
Total Equity Gross Minority Interest
4.44
Total Capitalization
5.86
Working Capital
-5.37
Invested Capital
11.14
Total Debt
7.88
Net Debt
5.47
Capital Lease Obligations
1.19
Net Tangible Assets
-0.92
Tangible Book Value
-0.92
Derivative Product Liabilities
0.00
Financial Assets
5.48
Preferred Shares Number
—
Preferred Stock Equity
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-3.23
+63.39%
-8.82
-593.24%
-1.27
+56.05%
-2.90
Cash Flow From Continuing Operating Activities
-3.23
+63.39%
-8.82
-593.24%
-1.27
+56.05%
-2.90
Net Income From Continuing Operations
-33.20
-108.55%
-15.92
-161.86%
-6.08
-22.47%
-4.96
Depreciation Amortization Depletion
3.00
+135.50%
1.27
-1.33%
1.29
-9.72%
1.43
Depreciation
0.03
+54.67%
0.02
-22.61%
0.02
-84.30%
0.14
Amortization Cash Flow
2.98
+136.62%
1.26
-0.95%
1.27
-1.42%
1.29
Depreciation And Amortization
3.00
+135.50%
1.27
-1.33%
1.29
-9.72%
1.43
Amortization Of Intangibles
2.98
+136.62%
1.26
-0.95%
1.27
-1.42%
1.29
Other Non Cash Items
3.04
+108.73%
1.46
+41.34%
1.03
-36.44%
1.62
Stock Based Compensation
7.13
+267.35%
1.94
+13.10%
1.72
+417.29%
0.33
Provisionand Write Offof Assets
—
—
0.26
0.00
Asset Impairment Charge
6.87
+2500.59%
0.26
+0.99%
0.26
—
Operating Gains Losses
5.47
+105.09%
2.67
—
-0.33
Gain Loss On Investment Securities
6.45
+140.60%
2.68
—
—
Change In Working Capital
4.45
+976.54%
-0.51
-200.35%
0.51
+151.40%
-0.99
Change In Receivables
-0.44
-41.80%
-0.31
-548.11%
-0.05
+89.84%
-0.47
Changes In Account Receivables
-0.44
-41.80%
-0.31
-548.11%
-0.05
+89.84%
-0.47
Change In Prepaid Assets
1.54
+223.72%
-1.24
-4609.90%
-0.03
+90.96%
-0.29
Change In Payables And Accrued Expense
1.56
+71.75%
0.91
+64.22%
0.55
+1746.08%
-0.03
Change In Other Working Capital
0.07
-51.51%
0.14
+2181.33%
-0.01
+88.13%
-0.06
Change In Other Current Assets
—
0.03
-9.75%
0.03
+125.16%
-0.14
Change In Other Current Liabilities
1.73
0.00
—
—
Investing Cash Flow
-0.54
+94.72%
-10.21
-3374.81%
-0.29
+91.65%
-3.52
Cash Flow From Continuing Investing Activities
-0.54
+94.72%
-10.21
-3374.81%
-0.29
+91.65%
-3.52
Net PPE Purchase And Sale
0.00
+100.00%
-0.16
-3749.70%
-0.00
+92.45%
-0.06
Purchase Of PPE
0.00
+100.00%
-0.16
-3749.70%
-0.00
+92.45%
-0.06
Capital Expenditure
-1.40
-58.19%
-0.89
-201.70%
-0.29
+2.20%
-0.30
Capital Expenditure Reported
-1.40
-92.98%
-0.73
-150.86%
-0.29
-18.03%
-0.25
Net Investment Purchase And Sale
0.00
+100.00%
-7.80
0.00
—
Purchase Of Investment
0.00
+100.00%
-7.80
0.00
—
Net Business Purchase And Sale
-0.87
+44.20%
-1.56
0.00
+100.00%
-3.22
Purchase Of Business
-0.87
+44.20%
-1.56
0.00
+100.00%
-3.22
Net Other Investing Changes
1.73
+6091.47%
0.03
—
—
Financing Cash Flow
2.75
-86.28%
20.06
+1086.24%
1.69
-73.90%
6.48
Cash Flow From Continuing Financing Activities
2.75
-86.28%
20.06
+1086.24%
1.69
-73.90%
6.48
Net Issuance Payments Of Debt
2.34
-64.33%
6.56
+419.99%
1.26
-54.13%
2.75
Issuance Of Debt
3.66
-53.03%
7.80
+117.48%
3.58
+9.92%
3.26
Repayment Of Debt
-1.32
-7.01%
-1.24
+46.82%
-2.32
-354.95%
-0.51
Long Term Debt Issuance
3.66
-53.03%
7.80
+117.48%
3.58
+9.92%
3.26
Long Term Debt Payments
-1.32
-7.01%
-1.24
+46.82%
-2.32
-354.95%
-0.51
Net Long Term Debt Issuance
2.34
-64.33%
6.56
+419.99%
1.26
-54.13%
2.75
Net Common Stock Issuance
0.41
-85.68%
2.88
+509.89%
0.47
-84.74%
3.10
Proceeds From Stock Option Exercised
—
0.00
+100.00%
-0.04
0.00
Net Other Financing Charges
—
-7.69
-16994.18%
-0.04
-107.11%
0.63
Changes In Cash
-1.02
-199.41%
1.02
+722.87%
0.12
+93.72%
0.06
Beginning Cash Position
1.22
+521.64%
0.20
+173.17%
0.07
+842.47%
0.01
End Cash Position
0.20
-83.42%
1.22
+521.64%
0.20
+173.17%
0.07
Free Cash Flow
-4.63
+52.29%
-9.71
-519.79%
-1.57
+50.98%
-3.20
Interest Paid Supplemental Data
0.22
+1095.93%
0.02
-97.31%
0.70
0.00
Common Stock Issuance
0.41
-85.68%
2.88
+509.89%
0.47
-84.74%
3.10
Issuance Of Capital Stock
0.41
-98.05%
21.19
+4386.56%
0.47
-84.74%
3.10
Net Preferred Stock Issuance
0.00
-100.00%
18.31
0.00
—
Preferred Stock Issuance
0.00
-100.00%
18.31
0.00
—
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category